Oppenheimer lowered Amgen (NASDAQ:AMGN) price target from $292 to $290By legume / April 28, 2023 / Amgen, Oppenheimer Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and lowers the price target from $292 to $290.